Abstract
The antibiotic, showdomycin, has a structural similarity to n-ethylmaleimide, a thiol binding reagent, and also to the nucleosides, uridine and pseudouridine. Its reactivity toward sulfhydryl-groups of susceptible proteins results from its maleimide-like structure and accounts for its cytotoxic effects. However, its nucleoside like structure is also related to its function as evidenced by the capacity of nucleosides to reverse its inhibitory effects on growth and on the transport of sugars and amino acids in Escherichia coli. This interesting specificity, as well as the remarkable changes which occur in showdomycin-resistant mutants of E. coli, are the basis for continued interest in this antibiotic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beljanski, M., Beljanski, M.: Synthèse dans Escherichia coli des ARN dont la structure primaire diffère totalement de celle de 1’ ADN. C. R. Acid. Sc. Paris, D 267, 1058–1060 (1968).
Beljanski, M., Beljanske, M., Bourgarel, P., Chassagne, J.: Synthèse chez les bactéries d’ARN nouveaux n’étant pas la copie de l’ADN. C. R. AcacL Se. Paris, D 269, 240–243 (1969).
Beljanski, M., Bourgarel, P., Beljanski, M.: Showdomycene et biosynthese d’ARN non-complementaires de F ADN. Ann. Inst. Pasteur. 118, 253–276 (1970).
Beljanski, M., Bourgarel, P., Beljanski, M.: Drastic alteration of ribosomal RNA and ribosomal proteins in showdomycin-resistant Escherichia coli. Proc. nat. Acad. Sci. (Wash.) 68, 491–495 (1971).
Beltz, R.E., Visser, D.W.: Growth inhibitiou of Escherichia coli by new thymidine analogs. J. Amer. chem. Soc. 77, 736–738 (1955).
Beltz, R.E., Visser, D.W.: Studies on the action of thymidine analogues. J. biol. Chem. 226, 1035–1045 (1957).
Ben-Ishai, R., Volcani, B.E.: Dependence of protein synthesis on ribonucleic acid formation in a thymine-requiring mutant of Escherichia coli. Biochim. biophys. Acta (Amst.) 21, 265–270 (1956).
Bermek, E., Kramer, W., Monkemeyer, H., Matthaei, H.: Mechanisms in protein synthesis XII. Sites of action of showdomycin in a cell-free polyphenylalanine synthesizing system from human lymphatic tissue: ribosomes and elongation factor TF II. Biochem. biophys. Res. Comm. 40, 1311–1318 (1970).
Darnall, K. R., Townsend, L.B., Robins, R.K.: The structure of showdomycin, a novel carbon-linked nucleoside antibiotic related to uridine. Proc. nat. Acad. Sci. (Wash.) 57, 548–553 (1967).
Dttnn, D.B., Smith, J. D.: The occurrence of 6-methylaminopurine in deoxyribonucleic acids. Biochem. J. 68, 627–635 (1958).
Friedland, M., Visser, D.W.: Studies on 5-aminodeoxyuridine. Biochim. biophys. Acta (Amst.) 51, 148–152 (1961).
Fukuhaba, T. K., Visser, D.W.: Uridine, cytidine, and deoxyuridine derivatives. Biochemistry 1, 563–568 (1962).
Grunberg-Manago, M., Michelson, A.M.: Polynucleotide analogues. II. Stimulation of amino acid incorporation by polynucleotide analogues. Biochim. biophys. Acta (Amst.) 80, 431– 440 (1964).
Hadler, H.I., Claybourn, B.E., Tsohang, T.P.: Mitochondrial volume changes induced by the antibiotic showdomycin. Biochem. biophys. Res. Comm. 31, 25–31 (1968).
Hadler, H.I., Moreau, T.L.: The induction of ATP energized mitochondrial volume changes by the combination of the two antitumor agents showdomycin and lapachol. J. Antibiot. 22, 513–520 (1969).
Huang, Y.H. J., Roy-Bttrman, D., Visser, D.W.: Uridine diphosphate glucose dehydrogenase of calf liver. Properties and inhibition characteristics with uridine diphosphate xylose analogues. Biochem. Pharmacol. 20, 2447–2453 (1971).
Kabat, S., Visser, D.W.: The incorporation of aminodeoxyuridine into deoxyribonucleic acid of Escherichia coli 15 T¯. Biochim. biophys. Acta (Amst.) 82, 680–681 (1964).
Kidder, G.W., Dewey, V.C.: The biological activity of substituted pyrimidines. J. biol. Chem. 178, 383–387 (1949).
Komatsu, Y., Tanaka, K.: Mechanism of action of showdomycin. Part I. Effect of show-domycin on the syntheses of nucleic acids and proteins in Escherichia coli K-12. Agr. biol. Chem. 82, 1021–1027 (1968).
Levene, P.A., La Forge, F.B.: Über die Hefe — Nucleinsäure. V. Die Struktur der Pyrimidin-Nucleoside Berichte der Deutschen Chemischen Gesellschaft 45, 608–620 (1912).
Matsuttra, S., Shiratori, O., Katagiri, K.: Antitumor activity of showdomycin. J. Antibiot. 17, 234–237 (1964).
Nakagawa, Y., Kano, H., Tsuda, T., Koyama, H.: Structure of a new class of C-nucleoside antibiotic showdomycin. Tetrahedron Lett. 42, 4105–4109 (1967).
Nishimura, H., Komatsu, Y.: Reversal of inhibiting action of showdomycin on the proliferation of Escherichia coli by nucleosides and thiol compounds. J. Antibiot. 21, 250–254 (1968).
Nishimura, H., Mayama, M., Komatsu, Y., Kato, H., Shimaoka, N., Tanaka, Y.: Showdomycin, a new antibiotic from a streptomyces sp. J. Antibiot. 17, 148–155 (1964).
Roberts, M., Visser, D.W.: Antimetabolite activity of uridine and cytidine derivatives. J. biol. Chem. 194, 695–701 (1952).
Roy-Burman, P.: Analogues of nucleic acid components. In: Rentchnick, P. (Ed.): Recent results in cancer research, p. 64–66. New York-Heidelberg-Berlin: Springer 1970.
Roy-Burman, P., Roy-Burman, S., Visser, D.W.: Uridine diphosphate glucose dehydrogenase. Studies with 5-hydroxyuridine diphosphate glucose and 5, 6-dihydrouridine diphosphate glucose. J. biol. Chem. 243, 1692–1697 (1968).
Roy-Bijrman, S., Huang, Y.H.J., Visser, D.W.: Inhibition of amino acid and sugar transport by showdomycin. Biochem. biophys. Res. Comm. 42, 445–453 (1971).
Roy-Burman, S., Roy-Burman, P., Visser, D.W.: Inhibition of ribonucleic acid polymerase by 5-hydroxyuridine 5’-triphosphate. J. biol. Chem. 241, 781–786 (1966).
Roy-Burman, S., Roy-Burman, P., Visser, D.W.:Showdomycin, a new nucleoside antibiotic. Cancer Res. 28, 1605–1610 (1968).
Roy-Burman, S., Roy-Burman, P., Visser, D.W.: Studies on the effect of triphosphates of 5-aminouridine and 5-hydroxydeoxyuridine on ribonucleic acid and deoxyribonucleic acid polymerases. Biochem. Pharmacol. 19, 2745–2756 (1970).
Slotnick, I.J., Visser, D.W., Rittenberg, S.C.: Growth inhibition of purine-requiring mutants of Escherichia coli by 5-hydroxyuridine. J. biol. Chem. 203, 647–652 (1953).
Slotnick, I.J., Visser, D.W., Rittenberg, S.C.: Degradation of substituted pyrimidine nucleosides by Escherichia coli and Bacillus subtilis. J. biol. Chem. 208, 217–223 (1954).
Smith, D.A., Roy-Burman, P., Visser, D.W.: Studies on 5-aminouridine. Biochim. biophys. Acta (Amst.) 119, 221–228 (1966).
Smith, D.A., Visser, D.W.: Studies on 5-hydroxyuridine. J. biol. Chem. 240, 446–453 (1965).
Smith, H.H., Fussel, C.P., Kugelman, B.H.: Partial synchronization of nuclear divisions in root meristems with 5-aminouracil. Science 142, 595 (1963).
Spiegelman, S., Halvorson, H.O., Ben-Ishai, R.: Free amino acids and the enzyme-forming mechanism. In: Mcelroy, W.D., Glass, B. (Eds.): A symposium on amino acid metabolism, p. 124–169. Baltimore: Johns Hopkins Press 1955.
Sugiurajk., Creech, H.J.: Merits of ascites tumors for chemotherapeutic screening. Ann. N.Y. Acad. Sci. 63, 962–982 (1956).
Theil, E., Zamenhof, S.: Studies on 6-methylaminopurine (6-methyladenine) in bacterial deoxyribonucleic acid. J. biol. Chem. 238, 3058–3064 (1963).
Thiry, L.: Viruses grown in the presence of base analogs: specific alteration of susceptibility to inactivation by radiations, mutagens, and protodyes. Virology 28, 543–554 (1966).
Titani, Y., Katsube, Y.: Radiosensitization of Escherichia coli B/r by showdomycin. Biochim. biophys. Acta (Amst.) 192, 367–369 (1969).
Titani, Y., Katsube, Y.: Enhancement of the lethal effect of alkylation to Escherichia coli B/r by showdomycin. J. Antibiot. 23, 43–44 (1970).
Ueda, T.: Studies on coenzyme analogs. III. Syntheses of 5-substituted uridine 5’-phosphates. Chem. pharm. Bull. 8, 455–458 (1960).
Visser, D.W.: Antimetabolites of nucleic acid precursors. In: Rhoads, C.P. (Ed.): Antimetabolites and cancer, pp. 47–62. Am. Soc. Adv. Sci. 1955.
Visser, D.W.: 5-Hydroxyuridine. In: Zorbach, W.W., Tipson, R.S. (Eds.): Synthetic procedures in nucleic acid chemistry, Vol. 1, pp. 428–430. New York: John Wiley & Sons 1968.
Visser, D.W.: 5-Aminouridine. In: Zorbach, W.W., Tipson, R.S. (Eds.): Synthetic procedures in nucleic acid chemistry, Vol. 1, p. 407–408. New York: John Wiley & Sons 1968a.
Visser, D. W., Lagerborg, D. L., Pearson, H. E.: Inhibition of mouse encephalomyelitis virus, in vitro, by certain nucleoprotein derivatives. Proc. Soc. exp. Biol. (N.Y.) 79, 571–573 (1952).
Visser, D.W., Roy-Burman, P.: 5-Hydroxyuridine 5’-phosphate derivatives. In: Zorbach, W.W., Tipson, R.S. (Eds.): Synthetic procedures in nucleic acid chemistry, Vol. 1, p. 493 to 496. New York: John Wiley & Sons 1968.
Visser, D.W., Roy-Burman, S.: Unpublished data, 1971.
Wacker, A., Kirscjhfield, S., Hartmann, D., Weinblum, U.D.: Über den Einbau von 5 nitrouraeil, 5-aminouracil und 2-thiothymin in die bakteriendeoxyribonukleinsäure. J. mol Biol. 2, 69–71 (1960).
Werkheiser, W.C., Visser, D.W.: Metabolie inhibitors and nucleotide turnover. II. Inhibition of uptake of C14-precursors in rat liver and hepatoma slices. Cancer Research 15, 644–649 (1955).
Werkheiser, W.C., Winzler, R. J., Visser, D.W.: Metabolie inhibitors and nucleotide turn over. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices. Cancer Res 15, 641–643 (1955).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Visser, D.W. (1975). Showdomycin, 5-Hydroxyuridine, and 5-Aminouridine. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive